Research output per year
Research output per year
Fingerprint
Dive into the research topics where Per Soelberg Sørensen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
-
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis
Sellebjerg, F., Royen, L., Soelberg Sørensen, P., Oturai, A. B. & Jensen, P. E. H., 1 Oct 2019, In: Multiple Sclerosis Journal.Research output: Contribution to journal › Journal article › Research › peer-review
-
Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A. G., Börnsen, L., Soelberg Sørensen, P., Sellebjerg, F. & Bang Oturai, A., 1 Aug 2019, In: Multiple Sclerosis Journal.Research output: Contribution to journal › Journal article › Research › peer-review
-
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X. & Mowry, E. M. & 10 others, , Feb 2018, In: Lancet Neurology. 17, 2, p. 162-173Research output: Contribution to journal › Review › peer-review
-
Disability in progressive MS is associated with T2 lesion changes
Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, P. S., Siebner, H. R. & Sellebjerg, F., Feb 2018, In: Multiple Sclerosis and Related Disorders. 20, p. 73-77Research output: Contribution to journal › Journal article › Research › peer-review
-
Early versus later treatment start in multiple sclerosis: a register-based cohort study
the Danish Multiple Sclerosis Group, 2018, In: European Journal of Neurology. 25, 10, p. 1262-e110Research output: Contribution to journal › Journal article › Research › peer-review
-
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T. & Pilling, S. & 7 others, , 1 Feb 2018, In: Multiple Sclerosis Journal. 24, 2, p. 96-120Research output: Contribution to journal › Journal article › Research › peer-review
-
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, P. S., Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 1 Apr 2018, In: Multiple Sclerosis Journal. 24, 5, p. 590-603Research output: Contribution to journal › Journal article › Research › peer-review
-
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study
Comi, G., Cook, S., Rammohan, K., Soelberg Sorensen, P., Vermersch, P., Adeniji, A. K., Dangond, F. & Giovannoni, G., 1 Jan 2018, In: Therapeutic Advances in Neurological Disorders. 11, p. 1-11Research output: Contribution to journal › Journal article › Research › peer-review